Patients with diabetes in primary-care settings frequently reported problems with pain/discomfort and restrictions in diet. Poorer health-related quality of life was found to be associated with higher HbA(1c) values. The chronicity of diabetes and insulin therapy may have a negative impact on patients' diabetes-related health-related quality of life. This study indicates the importance of achieving better disease management to improve the health-related quality of life of patients with diabetes.
A361patients were more likely to have annual cholesterol test, smoking status assessed, eye and renal function screening than normal weight patients. However, the overweight and obese class I/II patients were less likely to achieve optimal HbA1c (7% or less) and BP (< 130/80 mmHg) than normal BMI patients. The AdjOR for achieving optimal HbA1c decreased from 0.88 (95%CI 0.86-0.91) for overweight to 0.77 (0.72-0.83) for obese class II; and BP decreased from 0.74 (0.99-1.05) for overweight to 0.48 (0.45-0.52) for obesity class II. More obese class II and III patients had optimal LDLcholesterol control compared to normal BMI patients, AdjOR 1.11 (1.03-1.19) and 1.16 (1.04-1.29) respectively. ConClusions: Overweight and obese patients with diabetes were less likely to achieve the optimal HbA1c and BP control than normal BMI patients. Clinicians can identify the patients with higher BMI and poor risk factor control for more intense intervention to improve diabetes care and outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.